At least 68 “big” deals — investments of at least $2 million — have been done in digital health so far in 2012, according to a new report by the healthcare accelerator Rock Health. Nineteen states were in on the action.
Not so surprising, California lead the way in both the number of deals done and the overall investment. And traditional healthcare investing strongholds like Massachusetts were among those that did the most deals. But there were lesser known regions involved as well that invested significant dollars and did a notable number of deals, namely Texas, Illinois, Georgia and Connecticut.
Here’s a list of every region that did digital health deals so far this year.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
- California: 18 ($221.7 million)
- Texas: 7 ($104.2 million)
- Massachusetts: 6 ($37.3 million)
- Pennsylvania: 5 ($47.4 million)
- Illinois: 4 ($85.5 million)
- Connecticut: 4 ($9.3 million)
- Georgia: 3 ($38 million)
- New York: 3 ($23 million)
- Ohio: 3 ($15.5 million)
- Arizona: 2 ($15 million)
- Indiana: 2 ($8 million)
- North Carolina: 2 ($7.2 million)
South Dakota, Tennessee, Maryland, New Jersey, Washington, Wisconsin and Washington, D.C. each made one deal.
[Photo courtesy of Flickr user daveandlolo]
